Literature DB >> 19258356

Dopamine agonists and hyperprolactinaemia.

Niamh M Martin, Tricia Tan, Karim Meeran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19258356     DOI： 10.1136/bmj.b381

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Dopamine agonists for preventing ovarian hyperstimulation syndrome.

Authors:  Huilin Tang; Selma Mourad; Suo-Di Zhai; Roger J Hart
Journal:  Cochrane Database Syst Rev       Date:  2016-11-30

2.  The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial.

Authors:  Cristiano Busso; Manuel Fernández-Sánchez; Juan Antonio García-Velasco; José Landeras; Augustín Ballesteros; Elkin Muñoz; Sandra González; Carlos Simón; Joan-Carles Arce; Antonio Pellicer
Journal:  Hum Reprod       Date:  2010-02-06       Impact factor: 6.918

3.  Dopamine agonists for preventing ovarian hyperstimulation syndrome.

Authors:  Huilin Tang; Selma M Mourad; Aihua Wang; Suo-Di Zhai; Roger J Hart
Journal:  Cochrane Database Syst Rev       Date:  2021-04-14

4.  Bilateral angle-closure glaucoma in a young female receiving cabergoline: a case report.

Authors:  Hasan Razmjoo; Leila Rezaei; Alireza Dehghani; Alireza Peyman; Mohammadreza Akhlaghi
Journal:  Case Rep Ophthalmol       Date:  2011-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.